Age and Sex Effects on Blood Retrotransposable Element Expression Levels: Findings From the Population‐Based Rhineland Study
Year: 2025
Type: article
Study design: Observational Study
Abstract: Retrotransposable elements (RTEs) have been implicated in the pathogenesis of several age-associated diseases. Although model systems indicate that age- and sex-dependent loss of heterochromatin increases RTE expression, data from large human studies are lacking. Here we assessed the expression levels of 795 blood RTE subfamilies in 2467 participants of the population-based Rhineland Study. We found that the expression of more than 98% of RTE subfamilies increased with both chronological and biological age. Moreover, the expression of heterochromatin regulators involved in RTE silencing was negatively related to the expression of 690 RTE subfamilies. Finally, we observed sex differences in 42 RTE subfamilies, with higher expression in men. The genes mapped to sex-related RTEs were enriched in immune response-related pathways. Importantly, we validated our key findings in an independent population-based cohort. Our findings indicate that RTEs and their repressors are markers of aging and that their dysregulation is linked to inflammation, especially in men.
Source: Aging Cell
DOI: 10.1111/acel.70092
Authors: Valentina Talevi(Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Writing – original draft), Hang-Mao Lee(Conceptualization, Methodology, Writing – original draft), Dan Liu(Conceptualization, Data curation, Methodology, Writing – original draft), Marc D. Beyer, Paolo Salomoni(Conceptualization, Methodology, Supervision, Validation, Writing – original draft), Monique M.B. Breteler(Conceptualization, Funding acquisition, Methodology, Project administration, Supervision, Validation, Writing – original draft), N. Ahmad Aziz(Conceptualization, Methodology, Project administration, Supervision, Validation, Writing – original draft)
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,790
Funders: Alzheimer's Association, Deutsche Forschungsgemeinschaft, Bundesministerium für Bildung und Forschung, Ministerie van Volksgezondheid, Welzijn en Sport, Universitair Medisch Centrum Groningen, Deutsches Zentrum für Neurodegenerative Erkrankungen, Deutsche Krebshilfe, European Research Council, FP7 Ideas: European Research Council
Awards: G1285364889, SFB 1454: Metaflammation und Zelluläre Programmierung, G2771538467, The histone H3.3 variant in brain cancer pathogenesis, G3620252990, Biological Aging Underlies Neurodegeneration Across the Adult Lifespan, G4549622993, G528459802, GRK 2168: Myeloide antigenpräsentierende Zellen und Induktion adaptiver Immunität, G7880199332, EXC 2151: ImmunoSensation2 the immune sensory system, G8803244803, PreBeDem - Mit Prävention und Behandlung gegen Demenz
OpenAlex ID: W4410076014
